 "US FDA grants approval for ezetimibe tablet to Sun Pharma & Zydus Cadila")
The US Food & Drug Administration has granted marketing approval for ezetimibe tablet (10 mg) to two Indian companies - Sun Pharma and Zydus Cadila. Ezetimibe, a generic version of Merck’s Zetia tablet, is used to reduce high cholesterol levels.
“One of its wholly owned subsidiaries has received final approval from US FDA for its Abbreviated New Drug Application (ANDA) for generic version of Zetia (ezetimibe tablet 10 mg),” stated Sun Pharmaceutical in a press release.
In a separate statement, Zydus Cadila said, “Zydus has received the final approval from US FDA to market ezetimibe tablet (10 mg). It will be produced at the group’s formulations manufacturing facility at Moraiya, Ahmedabad.”
As per IMS, ezetimibe tablet had annual sales of approximately $2.7 billion in the US for the 12 months ended April 2017.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%